source:[1] Viatris Inc. (VTRS) Enters $515M IV Iron Market With FDA Green Light (https://finance.yahoo.com/news/viatris-inc-vt ...)[2] Viatris's Generic Iron Sucrose Injection Approval: A Strategic Win for Market Share and Cost-Saving in Healthcare - AInvest (https://vertexaisearch.cloud.google.com/groun ...)[3] Viatris stock rises after FDA approval of first generic iron sucrose - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)